- Home
- IOVA vs FIGS Comparison
IOVA vs FIGS Comparison
Compare IOVA & FIGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- FIGS
- Stock Information
- Founded
- IOVA 2007
- FIGS 2013
- Country
- IOVA United States
- FIGS United States
- Employees
- IOVA N/A
- FIGS N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- FIGS Apparel
- Sector
- IOVA Health Care
- FIGS Consumer Discretionary
- Exchange
- IOVA Nasdaq
- FIGS Nasdaq
- Market Cap
- IOVA 597.7M
- FIGS 694.0M
- IPO Year
- IOVA N/A
- FIGS 2021
- Fundamental
- Price
- IOVA $1.75
- FIGS $4.36
- Analyst Decision
- IOVA Buy
- FIGS Sell
- Analyst Count
- IOVA 10
- FIGS 4
- Target Price
- IOVA $12.22
- FIGS $4.50
- AVG Volume (30 Days)
- IOVA 19.4M
- FIGS 2.1M
- Earning Date
- IOVA 05-08-2025
- FIGS 05-08-2025
- Dividend Yield
- IOVA N/A
- FIGS N/A
- EPS Growth
- IOVA N/A
- FIGS N/A
- EPS
- IOVA N/A
- FIGS 0.01
- Revenue
- IOVA $212,679,000.00
- FIGS $561,166,000.00
- Revenue This Year
- IOVA $83.64
- FIGS $0.65
- Revenue Next Year
- IOVA $70.34
- FIGS $3.26
- P/E Ratio
- IOVA N/A
- FIGS $600.46
- Revenue Growth
- IOVA 11070.12
- FIGS 3.02
- 52 Week Low
- IOVA $1.64
- FIGS $3.57
- 52 Week High
- IOVA $12.51
- FIGS $7.06
- Technical
- Relative Strength Index (RSI)
- IOVA 33.50
- FIGS 46.03
- Support Level
- IOVA $1.70
- FIGS $4.36
- Resistance Level
- IOVA $1.87
- FIGS $4.66
- Average True Range (ATR)
- IOVA 0.15
- FIGS 0.20
- MACD
- IOVA 0.02
- FIGS -0.04
- Stochastic Oscillator
- IOVA 27.50
- FIGS 6.01
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About FIGS FIGS Inc.
FIGS Inc is a healthcare apparel company. The Company designs and sells scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear and other apparel. The Company generates maximum revenue from United States. Sales are generated through the Company's digital platforms.